CorMedix Q4 Earnings Call Highlights [Yahoo! Finance]
CorMedix Inc. (CRMD)
NASDAQ:AMEX Investor Relations:
cormedix.com
Company Research
Source: Yahoo! Finance
CorMedix (NASDAQ:CRMD) executives said 2025 was a “transformational” year, highlighted by DefenCath reaching peak sales of “just under $260 million,” the acquisition of Melinta Therapeutics, and the completion of targeted cost synergies by the fourth quarter. On the company's fourth-quarter and full-year 2025 earnings call, management also reiterated its outlook for 2026 and provided initial guidance for 2027 as DefenCath transitions out of its Transitional Drug Add-on Payment Adjustment (TDAPA) reimbursement period in outpatient hemodialysis. DefenCath reimbursement transition and guidance Chief Executive Officer Joseph Todisco said the key near-term focus is DefenCath's strategy in outpatient hemodialysis as TDAPA reimbursement transitions on July 1 from a buy-and-bill format to a bundled add-on mechanism. He said CorMedix has held “multiple conversations” with top customers and is finalizing supply pricing for the second half of 2026 as well as for 2027. ? IonQ in Rebound Mo
Show less
Read more
Impact Snapshot
Event Time:
CRMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRMD alerts
High impacting CorMedix Inc. news events
Weekly update
A roundup of the hottest topics
CRMD
News
- Cormedix Inc (CRMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]Yahoo! Finance
- CorMedix Inc. (CRMD) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateGlobeNewswire
- CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026 [Yahoo! Finance]Yahoo! Finance
CRMD
Earnings
- 3/5/26 - Miss
CRMD
Sec Filings
- 3/5/26 - Form 10-K
- 3/5/26 - Form 8-K
- 2/6/26 - Form 4
- CRMD's page on the SEC website